Blog
Launch Planning in Pharma: Why Patient and Stakeholder Mapping Matters More Than Ever
Mapping the right stakeholders early helps teams reduce friction, identify the real access pathways and improve launch execution before the first patient is treated.
Market access and launch planning in France require teams to understand not just the regulatory process, but also the stakeholders who influence adoption and funding. That means early mapping of patient groups, key opinion leaders, advocacy bodies, distributors and institutional decision-makers. When done correctly, this work sharpens commercial priorities and helps reduce the risk of misallocated effort.